CENTERPOINT ENERGY INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CENTERPOINT ENERGY INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	7,528	9,614	6,282	7,564	7,418	8,352	9,327	8,696	8,643	9,357
Cost of revenue	1,983	3,785	40	257	257	208	204	99	3	4
Gross profit	5,545	5,829	6,242	7,307	7,161	8,144	9,123	8,597	8,640	9,353
Operating income	1,023	1,136	868	1,071	1,039	1,363	1,566	1,760	1,990	2,110
Interest expense	338	313	361	528	501	508	524	701	838	903
Interest income			24	17	3		3	9
Other non-operating income	-337	-73	-317	-526	-476	-585	-149	-673	-776	-863
Pre-tax income	686	1,063	551	545	563	778	1,417	1,087	1,214	1,247
Income tax	254	-729	155	30	80	110	360	170	195	195
Income from continuing operations			396	515	483	668	1,057	917	1,019	1,052
Net income	432	1,792	368	791	-773	1,486	1,057	917	1,019	1,052
EBITDA	2,149	2,172	2,098	2,296	2,228	2,679	2,854	3,161	3,429	3,640
EPS, basic	1.00	4.16	0.74	1.34	-1.79	2.35	1.60	1.37	1.58	1.61
EPS, diluted	1.00	4.13	0.74	1.33	-1.79	2.28	1.59	1.37	1.58	1.60
Shares, basic (weighted)	431	431	449	502	531	593	629	631	643	653
Shares, diluted (weighted)	434	434	452	505	531	610	632	633	644	656
Dividend per share	1.03	1.35	1.12	0.86			0.72	0.78	0.83	0.89

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	341	260	4,231	241	147	230	74	90	24	38
Short-term investments	953	960	540	822	871	1,439	510	541	561	510
Receivables	740	1,000	1,190	702	676	690	889	710	717	806
Other current assets	161	241	192	123	121	132	171	145	123	140
Total current assets	2,923	3,395	7,025	3,937	2,920	7,355	4,699	3,027	4,381	5,701
Property, plant and equipment	12,307	13,057	14,044	20,624	22,362	23,484	27,143	29,853	32,089	34,056
Lease right-of-use assets				31	31	22	19	13	27	61
Goodwill	862	867	867	4,882	4,697	4,294	4,294	4,160	3,943	3,550
Intangible assets	49	74	65	321	50	44	38
Other non-current assets	173	191	158	236	253	220	215	162	247	222
Total assets	21,829	22,736	27,093	35,529	33,471	37,679	38,546	39,715	43,768	46,534
Accounts payable	657	963	1,240	884	853	1,196	1,352	917	1,320	1,300
Deferred revenue				124	119	111	110	111	93	89
Short-term debt	1,060	645	482	868	1,919	545	2,020	1,059	566	2,414
Total current liabilities	3,080	3,069	3,302	3,978	4,825	4,287	5,113	3,864	4,045	6,260
Long-term debt	7,532	8,195	8,682	14,244	11,521	15,558	14,836	17,559	20,397	20,566
Lease liabilities				42	26	17	14	10	25	57
Other non-current liabilities	278	357	402	738	1,019	836	774	766	722	770
Total liabilities	18,369	18,048	18,951	27,170	25,123	28,264	28,504	30,048	33,102	35,381
Total debt	8,557	8,195	8,682	14,244	11,521	15,558	14,836	17,559	20,397	20,566
Paid-in capital	4,195	4,209	6,072	6,080	6,914	8,529	8,568	8,604	9,105	9,130
Retained earnings	-668	543	349	632	-845	154	709	1,092	1,572	2,043
Other comprehensive income	-71	-68	-108	-98	-90	-64	-31	-35	-17	-26
Shareholders' equity	3,460	4,688	8,058	8,359	8,348	9,415	10,042	9,667	10,666	11,153
Total equity	3,460	4,688	8,058	8,359	8,348	9,415	10,042	9,667	10,666	11,153
Total liabilities and equity	21,829	22,736	27,009	35,529	33,471	37,679	38,546	39,715	43,768	46,534
Shares outstanding	431	431	501	502	551	629	630	631	652	653

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	432	1,792	368	791	-773	1,486	1,057	917	1,019	1,052
Depreciation and amortization	1,126	1,036	1,230	1,225	1,189	1,316	1,288	1,401	1,439	1,530
Deferred income tax	213	-770	48	69	-429	213	20	31	221	122
Change in inventory	34	-7	1	-52	9	-140	-259	167	42	-17
Change in payables	133	136	220	-455	2	175	203	-302	210	-15
Cash from operations	1,923	1,417	2,136	1,638	1,995	22	1,810	3,877	2,139	2,486
Capital expenditures	-1,414	-1,426	-1,651	-2,506	-2,596	-3,164	-4,419	-4,401	-4,513	-4,870
Acquisitions	-102	-132	0	-5,991	0	0
Purchases of investments	-363	0	0	-6	0
Sales and maturities of investments	178	0	398	0	0	1,320	702	0	0
Cash from investing	-1,034	-1,257	-1,207	-8,421	-1,265	-1,851	-1,628	-4,233	-4,489	-4,016
Debt issued	600	1,096	2,495	2,916	799	4,493	2,089	6,044	3,955	3,714
Debt repaid	-1,218	-1,211	-484	-1,302	-1,724	-2,968	-1,795	-3,190	-1,050	-1,579
Stock issued	0	0	1,844	0	672	0	0	0	494	0
Dividends paid	-443	-461	-499	-577	-392	-385	-440	-485	-522	-574
Cash from financing	-808	-245	3,053	2,776	-834	1,916	-345	374	2,271	1,549
Net change in cash	77	-81	3,982	-4,007	-104	87	-163	18	-79	19
Free cash flow	509	-9	485	-868	-601	-3,142	-2,609	-524	-2,374	-2,384
Interest paid	406	378	363	436	471	489	480	664	805
Income taxes paid	-104	15	89	155	143	-46	421	215	-9	-21

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2026; growth uses fiscal years. Valuation uses the share price of $36.84 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	100.0%	Gross profit / revenue.
Operating margin	22.6%	Operating income / revenue.
EBITDA margin	39.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	13.6%	Pre-tax income / revenue.
Net margin	11.4%	Net income / revenue.
FCF margin	-28.5%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	25.1%	Cash from operations / revenue.
Effective tax rate	16.2%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	9.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	2.2%	Net income / average total assets.
Return on invested capital (ROIC)	5.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Capex / revenue	53.6%	Capital expenditures / revenue.
D&A / revenue	17.0%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	8.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	0.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	4.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	8.3%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	0.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	5.5%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	6.0%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	10.4%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	15.2%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	6.2%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	8.4%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	10.3%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	3.2%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-0.2%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	1.3%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	0.2%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	16.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	11.2%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	4.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	7.2%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	7.3%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	4.6%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	3.6%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	6.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	6.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	6.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	6.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.8%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	1.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	4.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.16x	Current assets / current liabilities.
Quick ratio	0.39x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.22x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.96x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	47.0%	Total debt / total assets.
Liabilities / assets	76.1%	Total liabilities / total assets.
Net debt	$21.28B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	5.74x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	2.24x	Operating income / interest expense.
Working capital	$875.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	7.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	$7.90B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.20x	Revenue / average total assets.
Fixed asset turnover	0.27x	Revenue / average property, plant and equipment.
Receivables turnover	10.8x	Revenue / average receivables.
Days sales outstanding	34 days	365 x average receivables / revenue.
Days payables	93,349 days	365 x average accounts payable / cost of revenue.
FCF conversion	-249.5%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	213.3%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.62	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$14.22	Revenue / diluted weighted shares.
FCF per share	-$4.05	Free cash flow / diluted weighted shares.
Operating cash flow per share	$3.58	Cash from operations / diluted weighted shares.
Book value per share	$17.50	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$12.08	Tangible book value / shares outstanding.
Cash per share	$1.83	(Cash + short-term investments) / shares outstanding.
Payout ratio	54.2%	Dividends paid / net income, when net income is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$24.27B	Share price x shares outstanding.
Enterprise value	$45.55B	Market cap + total debt - cash - short-term investments.
P/E	22.7x	Market cap / net income. Only when net income is positive.
P/S	2.59x	Market cap / revenue.
P/B	2.12x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.07x	Market cap / tangible book value, when positive.
P/OCF	10.3x	Market cap / cash from operations, when positive.
EV/Sales	4.86x	Enterprise value / revenue.
EV/EBIT	21.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	12.3x	Enterprise value / EBITDA, when both are positive.
FCF yield	-11.0%	Free cash flow / market cap.
Earnings yield	4.4%	Net income / market cap (the inverse of P/E).
Dividend yield	2.4%	Dividends paid over the period / market cap.
Shareholder yield	2.4%	(Dividends paid + share buybacks) / market cap.
PEG	108x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was CENTERPOINT ENERGY INC's revenue in fiscal 2025?

CENTERPOINT ENERGY INC reported revenue of $9.36B for fiscal 2025, 8.3% higher than the year before.

Was CENTERPOINT ENERGY INC profitable in fiscal 2025?

Yes. Net income was $1.05B, a net margin of 11.2%.

How much free cash flow did CENTERPOINT ENERGY INC generate in fiscal 2025?

Cash from operations of $2.49B minus capital expenditures of $4.87B left free cash flow of -$2.38B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CENTERPOINT ENERGY INC